NEW YORK, NY --
Ocular Therapeutix (Nasdaq: OCUL), a biopharmaceutical company focused
on the development and commercialization of innovative therapies for
diseases and conditions of the eye, announced today that the
underwriters of its initial public offering have exercised in full their
over-allotment option to purchase an additional 750,000 shares at the
initial public offering price of $13.00 per share, less underwriting
American Financial Corporation (NYSE: FAF ),
a leading global provider of title insurance, settlement services and
risk solutions for real estate transactions, today announced that its board
of directors has declared a quarterly cash dividend of 24 cents per
WashingtonFirst Bankshares, Inc. (the “Company”) (NASDAQ: WFBI), today
announced that it has redeemed $4.4 million (4,449 shares), or 25% of
the $17.8 million outstanding Series D Preferred Stock ("Series D
Preferred Stock") that had been issued to the Secretary of the Treasury
("Treasury") in August 2011 through the Company's participation in the
Small Business Lending Fund ("SBLF"). The shares were redeemed at their
liquidation value of $1,000 per share plus accrued dividends through
August 14, 2014, for a total redemption price of $4,454,434.67.
The partial redemption was approved by the Company’s primary federal
regulator and funded with the Company’s surplus capital.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.